Cyclooxygenase-2 expression in endometrial cancer: Correlation with microvessel count and expression of vascular endothelial growth factor and thymidine phosphorylase

Human Pathology

Volumn 33, Issue 2, 2002, Pages 213-219

  Fujiwaki, Ritsuto ^a   Iida, Kohji ^a   Kanasaki, Haruhiko ^a   Ozaki, Tomoya ^a   Hata, Kohkichi ^a   Miyazaki, Kohji ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Cyclooxygenase 2; Endometrial cancer; Thymidine phosphorylase; Vascular endothelial growth factor

Indexed keywords

ANGIOGENIC FACTOR; CYCLOOXYGENASE 2; MESSENGER RNA; THYMIDINE PHOSPHORYLASE; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; ENZYME INHIBITION; EPITHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

EID: 0036219594     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2002.31292     Document Type: Article

References (38)

1. Cyclooxygenase in biology and disease
2. Prostaglandin synthase 2
3. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
4. Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis
5. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas
6. Expression of cyclooxygenase-2 in human gastric carcinoma
7. Expression of cyclo-oxygenase-2 in human lung carcinoma
8. Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder
9. Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor in human endometrial adenocarcinoma
10. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
11. Angiogenesis in endometrial hyperplasia and stage I endometrial carcinoma
12. Immunohistochemical expression of thymidine phosphorylase in human endometrial cancer
13. Co-expression of vascular endothelial growth factor and thymidine phosphorylase in endometrial cancer
14. Tumor angiogenesis and metastasisfs-correlation in invasive breast carcinoma
15. Molecular and biological properties of the vascular endothelial growth factor family of proteins
16. Thymidine phosphorylase in angiogenic and promotes tumor growth
17. Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis
18. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing
19. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors
20. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo
21. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
22. Host cyclooxygenase-2 modulates carcinoma growth
23. Immunohisto-chemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers
24. Expression of the thymidine phosphorylase gene in epithelial ovarian cancer
25. Biologic implications of the expression of vascular endothelial growth factor subtypes in ovarian carcinoma
26. Chemokine and cyclooxygenase-2 expression in human endometrium coincides with leukocyte accumulation
27. Expression of cyclo-oxygenase in human endometrium during the implantation period
28. Prostacyclin-mediated activation of peroxisome proliferator-activated receptor in colorectal cancer
29. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
30. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
31. Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer
32. Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients
33. Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma
34. Prostaglandins induce vascular endothelial growth factor in a human monocytic cell line and rat lungs via cAMP
35. Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy-5-fluorouridine
36. The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and and in vivo
37. Hypoxia induces cyclo-oxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells
38. COX-2 selective NSAIDs. New and improved?